Beyond growing teratoma syndrome: post-treatment manifestations and diagnostic challenges following ovarian immature teratoma

Growing teratoma syndrome (GTS) is a rare condition classically associated with platinum-based chemotherapy for malignant ovarian germ cell tumors. However, post-treatment findings following ovarian immature teratoma may represent a broader spectrum of entities that mimic recurrent malignancy and create substantial diagnostic challenges. Given the rarity of these conditions and their diverse clinical presentations, we present two illustrative cases managed at the Department of Gynecology and Gynecologic Oncology, University Hospital in Cracow, and review of the available literature. The first case involved a patient with ovarian immature teratoma who developed a classical post-chemotherapy GTS requiring surgical resection. During follow-up, a subsequent suspicious lesion demonstrated increased metabolic activity on positron emission tomography and was associated with mildly elevated tumor markers, raising concern for recurrent disease. Histopathological examination ultimately revealed a foreign-body granulomatous reaction. The second case involved a patient treated surgically for ovarian immature teratoma without adjuvant chemotherapy who subsequently developed peritoneal gliomatosis coexisting with deep infiltrating endometriosis, initially raising suspicion of intraperitoneal dissemination. These cases highlight the broad spectrum of post-treatment manifestations that may occur following ovarian immature teratoma. Enlarging masses, peritoneal implants, metabolically active lesions, and elevated tumor markers do not necessarily indicate malignant recurrence. Accurate diagnosis frequently requires correlation of imaging findings with surgical and histopathological assessment, and awareness of these rare entities is essential for appropriate management and surveillance.

growing teratoma syndromeovarian immature teratomaperitoneal gliomatosisdeep infiltrating endometriosisforeign body granuloma

- Tokunaga H, Mikami M, Nagase S, et al. The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. J Gynecol Oncol. 2021; 32(2): e49. - Brown J, Friedlander M, Backes F, et al. Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors. International Journal of Gynecological Cancer. 2014; 24: S48–S54. - Pallavi VR, Kansal Y, Rathod P, et al. Impact of Optimal Therapy and Prognostic Factors in Malignant Germ Cell Tumors of Ovary: 20 Years’ Institutional Experience. Indian Journal of Surgical Oncology. 2022; 13(3): 633–640. - Mangili G, Sigismondi C, Gadducci A, et al. Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors. International Journal of Gynecological Cancer. 2011; 21(8): 1414–1421. - Newton C, Murali K, Ahmad A, et al. A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice. European Journal of Cancer. 2019; 113: 19–27. - Smith HO, Berwick M, Verschraegen CF, et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol. 2006; 107(5): 1075–1085. - Park M, Lim J, Lee JAh, et al. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017. Gynecol Oncol. 2021; 163(1): 79–84. - Wang D, Zhu S, Jia C, et al. Diagnosis and management of growing teratoma syndrome after ovarian immature teratoma: A single center experience. Gynecol Oncol. 2020; 157(1): 94–100. - Bentivegna E, Azaïs H, Uzan C, et al. Surgical Outcomes After Debulking Surgery for Intraabdominal Ovarian Growing Teratoma Syndrome: Analysis of 38 Cases. Ann Surg Oncol. 2015; 22 Suppl 3: S964–S970. - Bonazzi C, Peccatori F, Colombo N, et al. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients. Obstet Gynecol. 1994; 84(4): 598–604. - Logothetis C, Samuels M, Trindade A, et al. The growing teratoma syndrome. Cancer. 1982; 50(8): 1629–1635, doi: 10.1002/1097-0142(19821015)50:83.0.co;2-1. - André F, Fizazi K, Culine S, et al. The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. Eur J Cancer. 2000; 36(11): 1389–1394. - Zagamé L, Pautier P, Duvillard P, et al. Growing teratoma syndrome after ovarian germ cell tumors. Obstet Gynecol. 2006; 108(3 Pt 1): 509–514. - Tonkin KS, Rustin GJ, Wignall B, et al. Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased. Eur J Cancer Clin Oncol. 1989; 25(12): 1739–1743. - Li S, Liu Z, Dong C, et al. Growing Teratoma Syndrome Secondary to Ovarian Giant Immature Teratoma in an Adolescent Girl: A Case Report and Literature Review. Medicine (Baltimore). 2016; 95(7): e2647. - Werner S, Numan T, Frederick P, et al. Growing teratoma syndrome in a chemotherapy naïve patient. Gynecol Oncol Rep. 2025; 60: 101815. - Li S, Su Na, Jia C, et al. Growing Teratoma Syndrome with Synchronous Gliomatosis Peritonei during Chemotherapy in Ovarian Immature Teratoma: A Case Report and Literature Review. Curr Oncol. 2022; 29(9): 6364–6372. - Bentivegna E, Gonthier C, Uzan C, et al. Gliomatosis peritonei: a particular entity with specific outcomes within the growing teratoma syndrome. Int J Gynecol Cancer. 2015; 25(2): 244–249. - Wang D, Jia CW, Feng RE, et al. Gliomatosis peritonei: a series of eight cases and review of the literature. J Ovarian Res. 2016; 9(1): 45. - Tangjitgamol S, Manusirivithaya S, Leelahakorn S, et al. The growing teratoma syndrome: a case report and a review of the literature. International Journal of Gynecological Cancer. 2006; 16: 384–390. - Khandelwal R, Giri S. Growing Teratoma Syndrome: A Review Article. Journal of South Asian Federation of Obstetrics and Gynaecology. 2022; 14(1): 81–83. - Imterat M, Bizzarri N, Stern S, et al. Gliomatosis peritonei with ovarian teratoma: an international multicenter case series. Int J Gynecol Cancer. 2026; 36(1): 102720. - Alna'irat M, McCluggage WG, Al-Hussaini M. Ovarian Immature Teratoma With Nodal Gliomatosis: A Case Report and Literature Review. Int J Gynecol Pathol. 2023; 42(6): 627–631. - Tantitamit T, U'wais A, Huang KG. An Ultralate Female Growing Teratoma Syndrome: 19 Years after Aggressive Treatment for Advanced Ovarian Immature Teratoma. Gynecol Minim Invasive Ther. 2020; 9(3): 150–153. - Spiess PE, Kassouf W, Brown GA, et al. Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience. J Urol. 2007; 177(4): 1330–4; discussion 1334. - Shefren G, Collin J, Soriero O. Gliomatosis peritonei with malignant transformation: a case report and review of the literature. Am J Obstet Gynecol. 1991; 164(6 Pt 1): 1617–20; discussion 1620.